Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results

NEXT STORY
Treace Announces Interim Results from ALIGN3D™ Clinical Study at ACFAS 2021
PREV STORY
Blood Plasma Derivatives Market Value Forecasted To Reach US$ 50.3 Billion By 2027 Covering COVID-19 Impact: Acumen Research And Consulting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Reports First Quarter 2019 Financial Results and Operational Highlights

author_avatar
NASDAQ Market News

Selecta Biosciences Announces Second Quarter 2017 Financial Results and Provides Corporate Update

Positive Data from Ongoing Phase 2 Study of SEL-212 Reported at Clinical Meetings in ...

author_avatar
NASDAQ Market News

Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab

author_avatar
NASDAQ Market News